Noveltreat Pre-filled Pen (Semaglutide) | GLP-1 Weight Loss & Type 2 Diabetes Therapy

Sold: 12 Orders Placed
In stock
SKU
SY000243
$0.00

Noveltreat Pre-filled Pen contains semaglutide, a long-acting GLP-1 receptor agonist designed for once-weekly subcutaneous administration. It is used for effective management of Type 2 diabetes  and chronic weight in patients with metabolic disorders.

Read More
Noveltreat 0.25 Mg Pre-filled Pen (Semaglutide 0.25mg/0.5ml)
PackageQTYPriceAdd To Cart
2.0 Pre-filled Pens $38.77
4.0 Pre-filled Pens $77.55
6.0 Pre-filled Pens $116.31

Noveltreat 0.5 Mg Pre-filled Pen (Semaglutide 0.5mg/0.5ml)
PackageQTYPriceAdd To Cart
2.0 Pre-filled Pens $43.22
4.0 Pre-filled Pens $86.44
6.0 Pre-filled Pens $129.66

Noveltreat 1 Mg Pre-filled Pen (Semaglutide 1mg/0.5ml)
PackageQTYPriceAdd To Cart
2.0 Pre-filled Pens $55.44
4.0 Pre-filled Pens $110.88
6.0 Pre-filled Pens $166.32

Noveltreat 1.7 Mg Pre-filled Pen (Semaglutide 1.7mg/0.75ml)
PackageQTYPriceAdd To Cart
2.0 Pre-filled Pens $72.11
4.0 Pre-filled Pens $144.22
6.0 Pre-filled Pens $216.33

Noveltreat 2.4 Mg Pre-filled Pen (Semaglutide 2.4mg/0.75ml)
PackageQTYPriceAdd To Cart
2.0 Pre-filled Pens $82.22
4.0 Pre-filled Pens $164.44
6.0 Pre-filled Pens $246.66

Product Overview

Noveltreat Pre-filled Pen acts as a hormonal analogue to regulate blood sugar levels and lower appetite, slows digestion and supports effective long-term management of chronic weight and Type 2 diabetes . It contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, once-weekly injectable medication designed to improve metabolic health in adults . By mimicking the natural hormones produced in the gastrointestinal tract, Noveltreat offers a comprehensive approach to managing chronic metabolic conditions. The pre-filled, metered-dose delivery system is specifically engineered for patient convenience, ensuring precise administration with minimal discomfort.

Product Composition
The efficacy of Noveltreat is centered on its highly stable active ingredient:

  • Semaglutide: A long-acting GLP-1 receptor agonist that enhances the body's natural insulin response and communicates with the brain to signal fullness.

Product Specification

FeatureDetails
Therapeutic ClassGLP-1 Receptor Agonist / Antidiabetic
AdministrationSubcutaneous Injection (SC)
Dosage FrequencyOnce Weekly
Delivery FormatDisposable, multi-dose pre-filled pen
Primary FocusGlycemic Control and Metabolic Regulation

 

Mechanism of Action

Noveltreat utilizes a multi-pathway mechanism to stabilize the body's internal environment:

  • Glucose-Dependent Insulin Release: It stimulates the pancreas to secrete insulin only when blood glucose levels are elevated, reducing the risk of hypoglycemia.
  • Glucagon Regulation: It suppresses the inappropriate secretion of glucagon, preventing the liver from releasing excess sugar into the bloodstream.
  • Gastric Emptying Modulation: By slowing the rate at which food moves through the digestive tract, it ensures a slower, more stable absorption of nutrients.
  • Satiety Signaling: The medication crosses the blood-brain barrier to target the hypothalamus, increasing feelings of satisfaction and reducing cravings for high-calorie foods.

Key Benefits

  • Long-Term Glycemic Stability: Successfully lowers HbA1c levels and helps maintain consistent blood sugar readings throughout the week.
  • Significant Metabolic Weight Loss: Supports meaningful weight reduction by addressing the hormonal drivers of hunger and calorie intake.
  • Cardiovascular Support: May offer protective benefits for the heart and vascular system in patients with established metabolic risks.
  • User-Friendly Delivery: The specialized pen design features a hidden needle and simple dial mechanism, making self-administration easy for those with needle anxiety.
  • Sustained Efficacy: Its long half-life ensures that the medication remains active in the system for seven days, allowing for a flexible but consistent weekly routine.

Precautions

Noveltreat Pre-filled Pen (Semaglutide) should be used carefully under medical supervision to ensure safe and effective control of blood sugar and weight management.

Medical Conditions to Inform Your Doctor

ConditionWhy It Matters
Pancreatitis historyMay increase risk of pancreatic inflammation
Thyroid disorders or thyroid cancer historyPossible risk in susceptible patients
Severe gastrointestinal diseaseMay worsen nausea, vomiting, and delayed gastric emptying
Kidney diseaseDehydration from side effects may affect kidney function
Diabetic retinopathyRapid blood sugar changes may temporarily worsen eye condition
Gallbladder diseaseMay increase risk of gallstones
 

 

Use and Dosing Precautions

  • Use exactly as prescribed (0.25 mg to 2.4 mg dose escalation schedule)
  • Administer once weekly on the same day each week
  • Do not increase or skip doses without doctor approval
  • Rotate injection sites (abdomen, thigh, or upper arm)

Gastrointestinal Effects

  • Nausea, vomiting, or diarrhea may occur during dose increases
  • Eat small, low-fat meals to reduce discomfort
  • Maintain adequate hydration

Hypoglycemia Risk

  • Risk increases when combined with insulin or sulfonylureas
  • Regular blood sugar monitoring is important

Pregnancy and Breastfeeding

  • Not recommended during pregnancy
  • Should be avoided during breastfeeding unless prescribed

General Advice

  • Do not stop treatment suddenly without medical advice
  • Store as per instructions (usually refrigerated)
  • Inform your doctor about all medications you are taking
  • Regular monitoring of blood sugar and weight is recommended

Usage

The effective use of the Noveltreat Pre-filled Pen depends on a consistent weekly schedule and a gradual increase in dosage to ensure the best results and patient comfort.

Dosage & Administration

Treatment typically begins with a low initiation dose and scales up every four weeks according to a medically supervised titration plan. This allows the digestive system to adapt to the medication.

AspectRecommendation
Standard FrequencyOnce weekly, on the same day each week
Administration RouteSubcutaneous (SC) injection only
Injection SitesFront of thighs, abdomen, or upper arm
Dose TimingCan be taken at any time of day, with or without meals

 

Administration Protocol

  • Pen Preparation: Before each use, verify that the liquid in the window is clear and colorless. Attach a new disposable needle for every injection to ensure sterility.

  • Selecting the Dose: Turn the dose selector until the counter shows the prescribed dose.

  • The Injection: Insert the needle into the skin. Press and hold the dose button until the counter returns to zero. Count to 6 before removing the needle to ensure the full amount has been delivered.

  • Rotation: It is important to rotate the injection site each week. Do not use the exact same spot for two consecutive injections.

  • Storage: Store unused pens in the refrigerator between 2°C and 8°C. Once a pen is in use, it can be stored at room temperature (below 30°C) or in the refrigerator for up to 56 days.

Uses

Noveltreat is a versatile hormonal therapy used to regulate systemic metabolic processes and improve long-term health outcomes.

  • Management of Type 2 Diabetes: Indicated as an adjunct to diet and exercise to improve blood sugar (glucose) levels in adults with type 2 diabetes.

  • Chronic Weight Management: Used to assist in long-term weight reduction for adults with a BMI in the obese or overweight range who also have weight-related medical issues.

  • HbA1c Reduction: Effectively works to lower "A1c" levels, providing a more stable and healthy long-term blood sugar profile.

  • Cardiovascular Risk Mitigation: Used to reduce the risk of major cardiovascular events, such as heart attack or stroke, in patients with type 2 diabetes and heart disease.

  • Appetite Control: Helps patients adhere to a reduced-calorie diet by slowing gastric emptying and signaling the brain to feel full sooner and for longer periods.

Side Effects

Noveltreat Pre-filled Pen (Semaglutide) may cause side effects, especially during dose escalation. Most effects are mild to moderate and improve with continued use.

Common Side Effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Abdominal pain or discomfort
  • Loss of appetite
  • Indigestion

Less Common Side Effects

  • Dizziness
  • Fatigue
  • Bloating
  • Acid reflux
  • Injection site reactions (redness, swelling, or itching)

Serious Side Effects

Serious ConditionSymptoms
PancreatitisSevere abdominal pain, vomiting, pain radiating to back
Severe hypoglycemiaSweating, confusion, shakiness, fainting
Gallbladder problemsUpper abdominal pain, fever, yellowing of skin or eyes
Severe dehydrationVery low urine output, dizziness, extreme thirst
Allergic reactionRash, swelling of face/lips, breathing difficulty
 

Important Advice

  • Side effects are more common during the first few weeks or dose increases
  • Eat smaller, low-fat meals to reduce nausea
  • Stay well hydrated to prevent dehydration
  • Report severe or persistent symptoms to a doctor immediately

FAQs

Q: What is Noveltreat Pre-filled Pen (Semaglutide) used for?
A: It is used for the treatment of type 2 diabetes and for weight management by helping control appetite and blood sugar levels.

Q: How does Noveltreat Semaglutide Pen work?
A: It works as a GLP-1 receptor agonist that increases insulin release, slows digestion, reduces appetite, and helps regulate blood sugar and body weight.

Q: How often is Noveltreat Pre-filled Pen used?
A: It is usually used once weekly as a subcutaneous injection, as prescribed by a doctor.

Q: What strengths are available for Noveltreat Pen?
A: It is available in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg strengths depending on the treatment phase.

Q: What are the common side effects of Noveltreat Pen?
A: Common side effects include nausea, vomiting, diarrhea, constipation, loss of appetite, and stomach discomfort.

Q: Can Noveltreat cause low blood sugar?
A: Yes, especially when used with insulin or sulfonylureas, so regular monitoring of blood glucose is important.

Q: How long does it take to see results?
A: Blood sugar improvement may be seen within weeks, while weight loss results usually take a few months with consistent use.

Q: Who should avoid Noveltreat Semaglutide Pen?
A: It should be avoided in patients with a history of medullary thyroid cancer, pancreatitis, or severe gastrointestinal disorders unless prescribed by a doctor.

Interactions

Noveltreat Pre-filled Pen (Semaglutide) may interact with certain medicines, affecting blood sugar control, drug absorption, and treatment response.

Antidiabetic Medicines

Medicine ClassInteraction Effect
InsulinIncreased risk of hypoglycemia (low blood sugar)
Sulfonylureas (e.g., glimepiride, gliclazide)Higher risk of low blood sugar, may require dose adjustment
Other GLP-1 receptor agonistsNot recommended due to additive effects and increased side effects
 

Other Medicines

  • Oral medications may have delayed absorption due to slowed gastric emptying
  • Warfarin may require closer INR monitoring due to changes in diet and absorption
  • Thyroid medicines (e.g., levothyroxine) may need timing adjustments for proper absorption
  • Diuretics may increase risk of dehydration, especially with nausea or vomiting

General Advice

  • Inform your doctor about all prescription, OTC, and herbal medicines
  • Monitor blood sugar regularly, especially when combined with insulin or sulfonylureas
  • Maintain proper hydration to reduce risk of kidney-related issues
  • Follow prescribed weekly dosing schedule strictly (0.25 mg to 2.4 mg)
  • Do not start, stop, or change dose without medical supervision
More Information
Manufacturer:Sun Pharma, India
Trade Name:Ozempic
Generic Search:Semaglutide
Strength:0.25mg, 5mg, 1mg , 1.7mg, 2.4mg
Write Your Own Review
You're reviewing:Noveltreat Pre-filled Pen (Semaglutide) | GLP-1 Weight Loss & Type 2 Diabetes Therapy
Your Rating